Richard Pratley

250PUBLICATIONS
545CO-AUTHORS
Gene and molecular therapyNeurology and neuromuscular diseasesPharmacogenomicsCardiology (incl. cardiovascular diseases)Sport and exercise nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (250)

|Sep 17, 2026
Initial Changes in eGFR during Treatment with Balcinrenone and Dapagliflozin: An Exploratory Analysis of the MIRO-CKD Trial.

|Sep 10, 2026
Coordinated clinical trial networks in nephrology: strengthening research infrastructure and improving trial delivery.

|Sep 04, 2026
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

|Aug 30, 2026
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

|Aug 04, 2026
Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD.

|Jul 30, 2026
Feasibility of Decentralised Response-Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease.

Pageof 42

Frequent Collaborators

43 joint publications

Peter Rossing

33 joint publications

Brendon L Neuen

27 joint publications

Clare G Arnott

23 joint publications

David Z I Cherney